Clinical Trial Update: A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC. [Phase 1, Phase 2]

View source ↗

Summary

Forward Pharmaceuticals is conducting a Phase I/II trial of FWD1802 in patients with ER+/HER2- advanced breast cancer (metastatic or locally advanced); recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FWD1802

Snippet

Sponsor: Forward Pharmaceuticals Co., Ltd. | Conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING